Silexion Therapeutics Corp (SLXN) — Institutional Holders, Q2 2026
25 institutional investment managers reported a SLXN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $101.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SLXN in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Polar Asset Management PartnersAdded · +669,127 sh+$20.3K
- LINDEN ADVISORSAdded · +303,750 sh+$9.2K
- ARISTEIA CAPITAL, L.L.C.Added · +212,891 sh+$6.5K
- Clear Street GroupAdded · +196,289 sh+$6.0K
- SECURITY BENEFIT LIFE INSURANCEAdded · +135,000 sh+$4.1K
Biggest sellers
- Saba Capital Management, L.P.Sold out · -1,194 sh-$36.00
SLXN 13F holders ranked 1–25 of 25
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Oasis Management Ltd.#1 · 11,111 sh | 11,111 | $28.3K | <0.01% | 0.0% |
| 2 | Polar Asset Management Partners#2 · 743,475 sh | 743,475 | $20.8K | <0.01% | 0.0% |
| 3 | LINDEN ADVISORS#3 · 337,500 sh | 337,500 | $9.5K | 0.00% | 0.0% |
| 4 | ARISTEIA CAPITAL, L.L.C.#4 · 236,546 sh | 236,546 | $6.6K | <0.01% | 0.0% |
| 5 | Clear Street Group#5 · 218,165 sh | 218,165 | $6.6K | 0.00% | -0.3% |
| 6 | SECURITY BENEFIT LIFE INSURANCE#6 · 150,000 sh | 150,000 | $4.6K | <0.01% | 0.0% |
| 7 | GOLDMAN SACHS GROUP#7 · 125,103 sh | 125,103 | $3.8K | 0.00% | +1.3% |
| 8 | UBS Group AG#8 · 1,411 sh | 1,411 | $3.6K | 0.00% | +172.9% |
| 9 | Kepos Capital#9 · 100,000 sh | 100,000 | $3.0K | <0.01% | 0.0% |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#10 · 92,073 sh | 92,073 | $2.8K | 0.00% | New |
| 11 | JANE STREET GROUP#11 · 74,910 sh | 74,910 | $2.3K | 0.00% | 0.0% |
| 12 | PICTON MAHONEY ASSET MANAGEMENT#12 · 57,175 sh | 57,175 | $1.7K | 0.00% | 0.0% |
| 13 | TENOR CAPITAL MANAGEMENT , L.P.#13 · 50,000 sh | 50,000 | $1.5K | 0.00% | 0.0% |
| 14 | GABELLI & INVESTMENT ADVISERS#14 · 38,150 sh | 38,150 | $1.2K | <0.01% | 0.0% |
| 15 | Mint Tower Capital Management B.V.#15 · 25,000 sh | 25,000 | $1.0K | <0.01% | 0.0% |
| 16 | DUPONT CAPITAL MANAGEMENT#16 · 32,500 sh | 32,500 | $988.00 | — | 0.0% |
| 17 | Neuberger Berman Group#17 · 31,552 sh | 31,552 | $959.00 | 0.00% | 0.0% |
| 18 | GABELLI FUNDS#18 · 30,496 sh | 30,496 | $927.00 | 0.00% | 0.0% |
| 19 | MONTAG A & ASSOCIATES#19 · 300 sh | 300 | $765.00 | 0.00% | -90.0% |
| 20 | STIFEL FINANCIAL#20 · 16,000 sh | 16,000 | $486.00 | 0.00% | 0.0% |
| 21 | Pflug Koory#21 · 33 sh | 33 | $84.00 | — | -90.1% |
| 22 | HRT FINANCIAL#22 · 15,239 sh | 15,239 | $38.00 | 0.00% | New |
| 23 | SBI Securities , Ltd.#23 · 2 sh | 2 | $5.00 | — | -90.0% |
| 24 | ROYAL BANK OF CANADA#24 · 76 sh | 76 | $0.00 | 0.00% | New |
| 25 | Context Capital Management#25 · 51,183 sh | 51,183 | — | — | 0.0% |
Funds that sold out of SLXN in Q2 2026 (4)
Held SLXN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| CITADEL ADVISORS2,093 sh | 2,093 | $26.8K |
| TWO SIGMA SECURITIES1,166 sh | 1,166 | $14.9K |
| Saba Capital Management, L.P.1,194 sh | 1,194 | $242.00 |
| JONES FINANCIAL COMPANIES LLLP3 sh | 3 | $32.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.